This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rudo, K. Articles by Langenbach, R. Search for Related Content PubMed PubMed Citation Articles by Rudo, K. Articles by Langenbach, R.

Comparison of Human and Rat Hepatocyte Metabolism and Mutagenic Activation of 2-Acetylaminofluorene

Cellular and Genetic Toxicology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [K. R. R. L.]; Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710 [W. C. M.]; Toxicology Program, North Carolina State University, Raleigh, North Carolina 27695 [W. D.]

A method has been developed to assess the metabolism and mutagenic activation of carcinogens using human and rodent hepatocytes in vitro. A slicing technique which was especially useful for nonperfusable biopsy and resected surgical human liver tissue was used to prepare the hepatocytes. Metabolites of the model carcinogen 2-acetylaminofluorene (AAF) produced by human and rat hepatocytes were similar and consisted primarily of 2-aminofluorene with ring hydroxylated products at the 1-, 3-, 5/9-, 7-, and 8-positions produced in addition to N-hydroxy-AAF. Sulphate and glucuronide conjugates of ring-hydroxylated metabolites and 2-aminofluorene were detected. Metabolism and cell-mediated Salmonella mutagenicity illustrated interindividual variation with human hepatocytes. Levels of metabolism and mutagenesis were generally higher with human hepatocytes compared to rat hepatocyte results. The increased levels of metabolism and mutagenesis of AAF by human hepatocytes compared to rat hepatocytes probably indicates a different sensitivity to hepatocarcinogenic effects of AAF on humans as compared to rats. Understanding differences and similarities between human and rodent carcinogen activation capabilities should be useful in the extrapolation of rodent carcinogenesis data to humans.

¹ To whom requests for reprints should be addressed, at Cellular and Genetic Toxicology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709.

Received 3/11/87. Revised 6/19/87. Revised 8/10/87. Accepted 8/18/87.

This article has been cited by other articles:

				G. M. Hawksworth Advantages and Disadvantages of Using Human Cells for Pharmacological and Toxicological Studies Human and Experimental Toxicology, January 1, 1994; 13(8): 568 - 573. [Abstract] [PDF]

				C. A. Tyson and N. H. Stacey In Vitro Screens From Cns, Liver and Kidney for Systemic Toxicity Toxicology and Industrial Health, January 1, 1989; 5(1): 107 - 132. [Abstract] [PDF]